VTYX
Ventyx Biosciences, Inc. (VTYX
NASDAQ · Healthcare · Biotechnology · US
$14.00
+0.00%Latest reported
- Last report date
- Nov 6, 2025
- EPS actual
- -$0.32
- EPS estimate
- -$0.45
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +21.8%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 6, 2025 | -$0.45 | -$0.32 | Beat 28.89% | — |
| Aug 7, 2025 | -$0.45 | -$0.38 | Beat 15.56% | — |
| May 8, 2025 | -$0.48 | -$0.39 | Beat 18.75% | — |
| Feb 27, 2025 | -$0.54 | -$0.41 | Beat 24.07% | — |
| Nov 7, 2024 | -$0.48 | -$0.50 | Miss -4.17% | — |
| May 9, 2024 | -$0.67 | -$0.62 | Beat 7.46% | — |
| Feb 27, 2024 | -$0.78 | -$0.79 | Miss -1.28% | $1.1M |
| Nov 9, 2023 | -$0.85 | -$0.92 | Miss -8.24% | — |
| Aug 10, 2023 | -$0.71 | -$0.91 | Miss -28.17% | — |
| May 11, 2023 | -$0.64 | -$0.68 | Miss -6.25% | — |
| Mar 23, 2023 | -$0.59 | -$0.62 | Miss -5.08% | — |
| Nov 3, 2022 | -$0.45 | -$0.59 | Miss -31.11% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 5, 2026